FDA Adverse Event Injury Summary report: N

IMPELLA

MDR report key: 24575555 · Received March 11, 2026

Report

Report Number
1220648-2026-05109
Event Type
Injury
Date Received
March 11, 2026
Date of Event
November 25, 2025
Manufacturer
ABIOMED, INC. - 1220648
Product Code
OZD
UDI-DI
00813502012828
PMA / PMN Number
P140003
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

D1 (BRAND NAME) & D4 (SERIAL) HAS BEEN UPDATED. D10 (CONCOMITANT) HAS BEEN ADDED. PPAE(TACHYCARDIA): THE ROOT CAUSE OF THE INJURY WAS NOT DETERMINED DUE TO INSUFFICIENT CLINICAL DETAILS.

Additional Manufacturer Narrative · 0

THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY ABIOMED INC, OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, ABIOMED INC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE.

Description of Event or Problem · 0

PATIENT WAS ADMITTED WITH RESPIRATORY SYMPTOMS. THE PATIENT WAS INITIALLY PLACED ON ECMO AND INOTROPES SECONDARY TO VIRAL CARDIOMYOPATHY. AN IMPELLA 5.5 WAS PLACED TO HELP WITH LEFT VENTRICULAR UNLOADING AND TO HELP TO WEAN OFF ECMO. THE PATIENT HAD MULTIPLE EPISODES OF VENTRICULAR TACHYCARDIA (VT) AND INITIAL PLAN WAS FOR ABLATION. ON (B)(6) 2025, THE PATIENT WAS IMPLANTED WITH A DURABLE VENTRICULAR ASSIST DEVICE WITH IMPELLA 5.5 EXPLANT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
595611 IMPELLA TEMPORARY NON-ROLLER TYPE LEFT HEART SUPPORT BLOOD PUMP OZD ABIOMED, INC. - 1220648 2026771215 00813502012828

Patients

Seq Age Sex Outcome Treatment
1 46 YR Male Required Intervention EXTRACORPOREAL MEMBRANE OXYGENATION